Ana Benitez Graham, MD
Dermatology · Mebane, NCNPI 1619197845
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 1,484 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,281, 2.5 times the $2,549 reported in 2019. Among dermatology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,484 payments — averaging $17.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$2K
- Amgen$2K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $12K from 31 others
What the payments were for
- Food & beverage$26,04898%
- Education$4372%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 240 | $5,168 |
| Johnson & Johnson | 102 | $2,283 |
| Regeneron Healthcare Solutions, Inc. | 89 | $1,968 |
| Sanofi | 78 | $1,705 |
| Amgen | 82 | $1,529 |
| E.r. Squibb & Sons, L.L.C. | 92 | $1,376 |
| Novartis | 87 | $1,350 |
| Arcutis Biotherapeutics, Inc. | 66 | $1,229 |
| Galderma Laboratories, L.p. | 96 | $1,197 |
| Sun Pharmaceutical Industries Inc. | 80 | $1,190 |
| UCB, Inc. | 68 | $1,157 |
| Lilly USA, LLC | 56 | $1,130 |
| Pfizer | 68 | $1,084 |
| Incyte Corporation | 80 | $884 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 48 | $732 |
| LEO Pharma Inc. | 29 | $463 |
| Mayne Pharma Commercial LLC | 27 | $370 |
| Dermavant Sciences, Inc. | 33 | $354 |
| Merz North America, Inc. | 3 | $188 |
| EPI Health, LLC | 10 | $160 |
| DUSA Pharmaceuticals, Inc. | 2 | $141 |
| VYNE Pharmaceuticals Inc. | 7 | $113 |
| Organon | 8 | $104 |
| Paratek Pharmaceuticals, Inc. | 4 | $95 |
| Almirall LLC | 6 | $90 |
| Bristol Myers Squibb | 5 | $85 |
| Sensus Healthcare, Inc. | 1 | $58 |
| Journey Medical Corporation | 3 | $55 |
| Genentech USA, Inc. | 3 | $54 |
| Dermira, Inc. | 2 | $36 |
| Botanix SB Inc | 2 | $36 |
| Prugen, Inc. Pharmaceuticals | 2 | $30 |
| Promius Pharma LLC | 1 | $24 |
| Boehringer Ingelheim | 1 | $17 |
| Taro Pharmaceuticals USA, Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Biofrontera Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,485 in reported general payments places this provider in the 90th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 23 | $191,572 |
| OtezlaApremilast | 40 | $189,945 |
| Taltz AutoinjectorIxekizumab | 13 | $92,696 |
| RinvoqUpadacitinib | 12 | $76,498 |
| Clobetasol Propionate | 333 | $16,171 |
| Ketoconazole | 308 | $5,290 |
| Triamcinolone Acetonide | 308 | $3,355 |
| Azelaic Acid | 34 | $2,666 |
| Doxepin Hcl | 62 | $2,442 |
| Mometasone Furoate | 131 | $1,913 |
| Tretinoin | 13 | $1,663 |
| Fluocinonide | 41 | $1,373 |
| Doxycycline Hyclate | 41 | $1,347 |
| Hydroxyzine Hcl | 69 | $1,187 |
| Fluorouracil | 18 | $1,041 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $1,529 | $189,94540 claims |
| AbbVieRinvoq | $5,168 | $76,49812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 475 dermatology providers in North Carolina.
Other dermatology in Mebane
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
- Rosalyn GeorgeWilmington$346K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.